Concord Medical Services Holdings Ltd (CCM) stock
Close on Nov 11, 2026Market cap $15.11MP/E –Yield –
Concord Medical Services Holdings Ltd grew revenue 19.9% to CN¥460.51M over fiscal 2025. Free cash flow was -CN¥258.15M. At the latest close the market valued the company at CN¥100.87M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- CN¥100.87M
- P/E ratio
- –
- Price to sales
- 0.22
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -255.92%
Fundamentals
- Revenue
- CN¥460.51M
- Net income
- -CN¥92.81M
- EPS, diluted
- -0.71 CNY
- Free cash flow
- -CN¥258.15M
Trading
- Previous close
- $3.68
- Open
- $3.58
- Day's range
- $3.42 – $3.68
- Volume
- 7,803
- Average volume (20 days)
- 16,254
- Beta (5 years)
- 0.31
- RSI (14 days)
- 45.6
- Volatility (1 year)
- 89.7%
- Relative volume
- 0.16×
- WACC
- 4.0%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CCM | S&P 500 | Difference | CCM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.3% | -2.4% | −7.9 pts | ||
| 3 months | -32.8% | -1.2% | −31.7 pts | ||
| Year to date | -9.8% | +12.3% | −22.1 pts | ||
| 1 year | -29.8% | +12.4% | −42.3 pts | ||
| 3 years | -68.6% | +78.8% | −147.5 pts | -32.1% | +21.4% |
| 5 years | -86.1% | +75.2% | −161.2 pts | -32.6% | +11.9% |
| 10 years | -92.1% | +311.1% | −403.2 pts | -22.4% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025, CNY
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Concord Medical Services filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Concord Medical Services
Services-Offices & Clinics of Doctors of Medicine
Concord Medical Services Holdings Limited operates oncology healthcare facilities and provides medical equipment solutions in China. The company operates across two primary segments: hospital business and network business. Through its healthcare facilities, it delivers cancer care across the treatment continuum to patients, including screening, diagnosis, radiation therapy, and inpatient services. Through its network business, the company leases radiotherapy and diagnostic imaging equipment, sells medical devices, and offers technical support, management, teleconsultation, and medical software solutions to partner hospitals and other healthcare enterprises.
Company profile, executives and historyConcord Medical Services stock: common questions
What is Concord Medical Services's stock price?
CCM closed at $3.48 on Nov 11, 2026, down 5.43% on the day.
What is Concord Medical Services's market cap?
Concord Medical Services was worth $15.11M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CCM's P/E ratio?
Concord Medical Services lost money over fiscal 2025 (diluted EPS -0.71 CNY), so it has no meaningful P/E ratio.
How much revenue does Concord Medical Services make?
Concord Medical Services reported revenue of CN¥460.51M for fiscal 2025, up 19.9% from a year earlier.
Does Concord Medical Services pay a dividend?
No. Concord Medical Services has not paid a cash dividend over the last twelve months.
How has CCM stock performed over the past year?
Including dividends, CCM returned -29.8% over the past year, against +12.4% for the S&P 500.
Who are Concord Medical Services's competitors?
Companies most similar to Concord Medical Services by business, industry and size include STLN, SBC, BNR, LFMD, AUNA.
See a number that looks wrong?